Načítá se...
Cost-effectiveness analysis of azacitidine in the treatment of high-risk myelodysplastic syndromes in Spain
BACKGROUND: The objective of the study was to analyse whether azacitidine is a cost-effective option for the treatment of myelodysplastic syndrome in the Spanish setting compared with conventional care regimens, including best supportive care, low dose chemotherapy and standard dose chemotherapy. ME...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4029489/ https://ncbi.nlm.nih.gov/pubmed/24314138 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2191-1991-3-28 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|